PRESS RELEASES

CAR T-cell therapy
CAR T-cell therapy – Clinical Edge Issue 3
Inside next-gen platforms
Inside next-gen platforms for cell therapy manufacturing
Immunotherapy advancements in cancer
Immunotherapy advancements: transforming cancer treatment
CD5 deletion enhances T-cell therapies
CD5 deletion enhances the antitumor activity of adoptive T cell therapies
Nicholas Siciliano discusses the future of CAR-T
Insider insights: Vittoria CEO Nicholas Siciliano on the future of CAR-T